Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

PDL BioPharma Gross Profit 2006-2019 | PDLI

PDL BioPharma gross profit from 2006 to 2019. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
  
PDL BioPharma Annual Gross Profit
(Millions of US $)
2018 $150
2017 $290
2016 $240
2015 $590
2014 $581
2013 $456
2012 $381
2011 $362
2010 $345
2009 $318
2008 $294
2007 $225
2006 $187
2005 $158
PDL BioPharma Quarterly Gross Profit
(Millions of US $)
Q3 2019 $29
Q2 2019 $-35
Q1 2019 $26
Q4 2018 $34
Q3 2018 $56
Q2 2018 $32
Q1 2018 $28
Q4 2017 $50
Q3 2017 $57
Q2 2017 $139
Q1 2017 $43
Q4 2016 $66
Q3 2016 $54
Q2 2016 $21
Q1 2016 $103
Q4 2015 $178
Q3 2015 $125
Q2 2015 $138
Q1 2015 $150
Q4 2014 $117
Q3 2014 $165
Q2 2014 $163
Q1 2014 $137
Q4 2013 $116
Q3 2013 $100
Q2 2013 $149
Q1 2013 $92
Q4 2012 $92
Q3 2012 $85
Q2 2012 $126
Q1 2012 $77
Q4 2011 $73
Q3 2011 $84
Q2 2011 $122
Q1 2011 $83
Q4 2010 $76
Q3 2010 $86
Q2 2010 $120
Q1 2010 $62
Q4 2009 $58
Q3 2009 $71
Q2 2009 $126
Q1 2009 $63
Q4 2008 $69
Q3 2008 $69
Q2 2008 $107
Q1 2008 $50
Q4 2007 $50
Q3 2007 $61
Q2 2007 $89
Q1 2007 $59
Q4 2006 $60
Q3 2006 $94
Q2 2006 $83
Q1 2006 $68
Q4 2005 $67
Q3 2005 $55
Q2 2005 $61
Q1 2005 $38
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.372B $0.198B
Protein Design Labs Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a leader in the development of humanized antibodies, PDL has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $139.657B 16.09
CSL (CSLLY) Australia $95.348B 0.00
Gilead Sciences (GILD) United States $80.893B 10.02
Vertex Pharmaceuticals (VRTX) United States $60.150B 61.39
Biogen (BIIB) United States $51.283B 8.80
Illumina (ILMN) United States $48.069B 52.74
Regeneron Pharmaceuticals (REGN) United States $39.153B 17.14
Alexion Pharmaceuticals (ALXN) United States $24.021B 11.86
Seattle Genetics (SGEN) United States $19.769B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $19.134B 0.00
Incyte (INCY) United States $16.853B 39.12
BioMarin Pharmaceutical (BMRN) United States $15.381B 0.00
Genmab (GNMSF) Denmark $14.047B 62.04
Alnylam Pharmaceuticals (ALNY) United States $13.151B 0.00
Galapagos (GLPG) Belgium $12.724B 32.78
Exact Sciences (EXAS) United States $11.968B 0.00
Bio-Rad Laboratories (BIO.B) United States $11.238B 53.94
BeiGene (BGNE) Cayman Islands $10.324B 0.00
Sarepta Therapeutics (SRPT) United States $8.474B 0.00
Bio-Techne Corp (TECH) United States $8.337B 55.81
BioNTech SE (BNTX) Germany $8.304B 0.00
QIAGEN (QGEN) Netherlands $7.852B 25.60
Guardant Health (GH) United States $7.655B 0.00
Amarin (AMRN) Ireland $7.416B 0.00
Moderna (MRNA) United States $7.155B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.951B 17.67
ACADIA Pharmaceuticals (ACAD) United States $6.283B 0.00
Reata Pharmaceuticals (RETA) United States $6.261B 0.00
Exelixis (EXEL) United States $5.946B 16.73
Ascendis Pharma (ASND) Denmark $5.773B 0.00
ARGENX SE-ADR (ARGX) Netherlands $5.687B 0.00
Repligen (RGEN) United States $5.190B 94.05
Bluebird Bio (BLUE) United States $4.964B 0.00
China Biologic Products (CBPO) China $4.584B 25.83
MorphoSys AG (MOR) Germany $4.207B 0.00
Immunomedics (IMMU) United States $3.587B 0.00
Mirati Therapeutics (MRTX) United States $3.523B 0.00
NeoGenomics (NEO) United States $3.444B 183.28
Adaptive Biotechnologies (ADPT) United States $3.339B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.306B 0.00
Blueprint Medicines (BPMC) United States $3.306B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.262B 0.00
MyoKardia (MYOK) United States $3.233B 0.00
Zai Lab (ZLAB) China $3.175B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.123B 0.00
Emergent Biosolutions (EBS) United States $3.000B 29.80
Genmab (GMAB) Denmark $2.959B 6.10
Halozyme Therapeutics (HALO) United States $2.882B 0.00
Alkermes (ALKS) Ireland $2.867B 0.00
Momenta Pharmaceuticals (MNTA) United States $2.811B 0.00
Acceleron Pharma (XLRN) United States $2.800B 0.00
UniQure (QURE) Netherlands $2.698B 0.00
Epizyme (EPZM) United States $2.434B 0.00
Denali Therapeutics (DNLI) United States $2.391B 0.00
Amicus Therapeutics (FOLD) United States $2.362B 0.00
Arena Pharmaceuticals (ARNA) United States $2.295B 5.34
RA PHARMCTL INC (RARX) United States $2.209B 0.00
Myriad Genetics (MYGN) United States $2.142B 31.64
Principia Biopharma (PRNB) United States $1.974B 0.00
Fate Therapeutics (FATE) United States $1.878B 0.00
Insmed (INSM) United States $1.807B 0.00
Akcea Therapeutics (AKCA) United States $1.798B 0.00
Zymeworks (ZYME) Canada $1.776B 0.00
Arvinas (ARVN) United States $1.716B 0.00
REGENXBIO (RGNX) United States $1.661B 0.00
Alector (ALEC) United States $1.604B 0.00
Ligand Pharmaceuticals (LGND) United States $1.580B 30.39
Editas Medicine (EDIT) United States $1.486B 0.00
Intra-Cellular Therapies (ITCI) United States $1.378B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.352B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.339B 0.00
Coherus BioSciences (CHRS) United States $1.313B 0.00
Zealand Pharma (ZLDPF) Denmark $1.292B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.289B 0.00
Athenex (ATNX) United States $1.163B 0.00
Zealand Pharma (ZEAL) Denmark $1.161B 0.00
DBV Technologies S.A (DBVT) France $1.059B 0.00
Mesoblast (MESO) Australia $1.054B 0.00
Revance Therapeutics (RVNC) United States $1.007B 0.00
Codexis (CDXS) United States $1.002B 0.00
PHARMA MAR SA (PHMMF) Spain $0.965B 0.00
Sangamo Therapeutics (SGMO) United States $0.929B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.915B 0.00
Pharming Group (PHGUF) Netherlands $0.909B 0.00
Heska (HSKA) United States $0.853B 218.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.813B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.800B 6.73
Adverum Biotechnologies (ADVM) United States $0.752B 0.00
Cytokineticsorporated (CYTK) United States $0.748B 0.00
Vericel (VCEL) United States $0.748B 278.83
ANI Pharmaceuticals (ANIP) United States $0.745B 12.71
GENFIT S.A (GNFT) France $0.734B 0.00
Twist Bioscience (TWST) United States $0.725B 0.00
Retrophin (RTRX) United States $0.713B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.708B 0.00
Cellectis S.A (CLLS) France $0.704B 0.00
Sorrento Therapeutics (SRNE) United States $0.703B 0.00
Intellia Therapeutics (NTLA) United States $0.690B 0.00
NantKwest (NK) United States $0.666B 0.00
Anika Therapeutics (ANIK) United States $0.656B 21.28
Cara Therapeutics (CARA) United States $0.654B 0.00
UROGEN PHARMA (URGN) United States $0.648B 0.00
AC Immune SA (ACIU) Switzerland $0.625B 14.45
Kadmon Holdings (KDMN) United States $0.581B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.568B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.548B 0.00
Prothena (PRTA) Ireland $0.535B 0.00
Agenus (AGEN) United States $0.527B 0.00
BioDelivery Sciences (BDSI) United States $0.521B 0.00
Precision BioSciences (DTIL) United States $0.513B 0.00
Cel-Sci (CVM) United States $0.508B 0.00
Clovis Oncology (CLVS) United States $0.505B 0.00
Dynavax Technologies (DVAX) United States $0.481B 0.00
Bellus Health (BLU) Canada $0.477B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Arcus Biosciences (RCUS) United States $0.434B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.422B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.405B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.401B 0.00
AnaptysBio (ANAB) United States $0.401B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.397B 0.00
Merus (MRUS) Netherlands $0.396B 0.00
Inovio Pharmaceuticals (INO) United States $0.384B 0.00
Avid Bioservices (CDMO) United States $0.383B 0.00
Mersana Therapeutics (MRSN) United States $0.379B 0.00
Kindred Biosciences (KIN) United States $0.378B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.366B 2.53
Gritstone Oncology (GRTS) United States $0.360B 0.00
Pfenex (PFNX) United States $0.358B 0.00
MannKind (MNKD) United States $0.351B 0.00
OSMOTICA PHARM (OSMT) United States $0.350B 0.00
POXEL SA FRANCE (PXXLF) France $0.350B 0.00
Cue Biopharma (CUE) United States $0.350B 0.00
CytomX Therapeutics (CTMX) United States $0.349B 0.00
Stemline Therapeutics (STML) United States $0.347B 0.00
Puma Biotechnology (PBYI) United States $0.344B 0.00
Syros Pharmaceuticals (SYRS) United States $0.338B 0.00
Compugen (CGEN) Israel $0.334B 0.00
Cellular Biomedicine (CBMG) United States $0.329B 0.00
Starpharma Holdings (SPHRY) Australia $0.305B 0.00
Albireo Pharma (ALBO) United States $0.300B 0.00
IVERIC Bio (ISEE) United States $0.281B 0.00
Geron (GERN) United States $0.280B 0.00
Kamada (KMDA) Israel $0.275B 8.05
Sutro Biopharma (STRO) United States $0.270B 0.00
ADMA Biologics Inc (ADMA) United States $0.269B 0.00
WAVE Life Sciences (WVE) Singapore $0.268B 0.00
Prometic Life Sciences (LMNL) Canada $0.261B 0.00
Biofrontera AG (BFRA) Germany $0.254B 0.00
ChromaDex (CDXC) United States $0.251B 0.00
Seres Therapeutics (MCRB) United States $0.246B 0.00
Novavax (NVAX) United States $0.246B 0.00
VBI Vaccines (VBIV) United States $0.230B 0.00
Exicure (XCUR) United States $0.226B 0.00
Affimed (AFMD) Germany $0.224B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.221B 0.00
Theratechnologies (THTX) Canada $0.219B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.215B 0.00
Five Prime Therapeutics (FPRX) United States $0.212B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.209B 0.00
Athersys (ATHX) United States $0.208B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.207B 0.00
Cerecor (CERC) United States $0.204B 0.00
XOMA (XOMA) United States $0.203B 0.00
Protagonist Therapeutics (PTGX) United States $0.202B 0.00
Aptinyx (APTX) United States $0.202B 0.00
Arbutus Biopharma (ABUS) Canada $0.194B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.191B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.190B 0.00
Fortress Biotech (FBIO) United States $0.187B 0.00
Spero Therapeutics (SPRO) United States $0.184B 0.00
Windtree Therapeutics (WINT) United States $0.181B 0.00
Alcobra (ARCT) United States $0.181B 0.00
TELA Bio (TELA) United States $0.179B 0.00
CorMedix Inc (CRMD) United States $0.171B 0.00
PHASEBIO PHARMA (PHAS) United States $0.166B 0.00
Strongbridge Biopharma (SBBP) United States $0.165B 4.41
Palatin Technologies (PTN) United States $0.163B 4.45
ARAVIVE, INC (ARAV) United States $0.160B 0.00
Selecta Biosciences (SELB) United States $0.154B 0.00
Applied Genetic Technologies (AGTC) United States $0.152B 0.00
Dyadic (DYAI) United States $0.151B 0.00
Menlo Therapeutics (MNLO) United States $0.146B 0.00
Abeona Therapeutics (ABEO) United States $0.144B 0.00
Verastem (VSTM) United States $0.144B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.142B 7.31
VTv Therapeutics (VTVT) United States $0.137B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Liquidia Technologies (LQDA) United States $0.133B 0.00
Aduro Biotech (ADRO) United States $0.127B 0.00
Northwest Biotherapeutics (NWBO) United States $0.124B 0.00
Clearside Biomedical (CLSD) United States $0.122B 0.00
Enzo Biochem (ENZ) United States $0.121B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.121B 0.00
Arsanis (XFOR) United States $0.119B 0.00
OvaScience (MLND) United States $0.114B 0.00
Acorda Therapeutics (ACOR) United States $0.114B 0.00
Happiness Biotech Group (HAPP) China $0.113B 0.00
Celyad SA (CYAD) Belgium $0.111B 0.00
Antibe Therapeutics (ATBPF) Canada $0.108B 0.00
SESEN BIO, INC (SESN) United States $0.097B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.097B 0.00
Proteostasis Therapeutics (PTI) United States $0.096B 0.00
AIT Therapeutics (XAIR) United States $0.089B 0.00
Synlogic (SYBX) United States $0.088B 0.00
Adocia (ADOCY) France $0.086B 0.00
Trevena (TRVN) United States $0.084B 0.00
Catalyst Biosciences (CBIO) United States $0.082B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.082B 0.00
Emmaus Life Sciences (EMMA) United States $0.081B 0.00
Prima BioMed (IMMP) Australia $0.078B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.077B 0.00
Orgenesis (ORGS) United States $0.076B 4.93
Vaccinex (VCNX) United States $0.076B 0.00
Checkpoint Therapeutics (CKPT) United States $0.075B 0.00
NewLink Genetics (NLNK) United States $0.075B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.066B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.063B 0.00
Soligenix (SNGX) United States $0.062B 0.00
Pluristem Therapeutics (PSTI) Israel $0.060B 0.00
Protalix BioTherapeutics (PLX) Israel $0.056B 0.00
Idera Pharmaceuticals (IDRA) United States $0.055B 0.00
Curis (CRIS) United States $0.055B 0.00
Vascular Biogenics (VBLT) Israel $0.051B 0.00
AquaBounty Technologies (AQB) United States $0.049B 0.00
DiaMedica Therapeutics (DMAC) United States $0.048B 0.00
Organovo Holdings (ONVO) United States $0.046B 0.00
Evogene (EVGN) Israel $0.044B 0.00
CollPlant Holdings (CLGN) Israel $0.041B 0.00
Celldex Therapeutics (CLDX) United States $0.038B 0.00
Alimera Sciences (ALIM) United States $0.037B 0.00
BioCardia (BCDA) United States $0.036B 0.00
Celsion (CLSN) United States $0.036B 0.00
Unum Therapeutics (UMRX) United States $0.035B 0.00
Entera Bio (ENTX) Israel $0.035B 0.00
Pulmatrix (PULM) United States $0.032B 0.00
VistaGen Therapeutics (VTGN) United States $0.032B 0.00
Bionano Genomics (BNGO) United States $0.031B 0.00
Oncobiologics (OTLK) United States $0.030B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
AmpliPhi Biosciences (ARMP) United States $0.029B 0.00
VIVUS (VVUS) United States $0.028B 0.00
Novogen (KZIA) Australia $0.027B 0.00
AEterna Zentaris (AEZS) United States $0.027B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.026B 0.00
Stellar Biotechnologies (EDSA) Canada $0.025B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.022B 0.00
Signal Genetics (MGEN) United States $0.022B 0.00
Genetic Technologies (GENE) Australia $0.019B 0.00
Titan Pharmaceuticals (TTNP) United States $0.018B 0.00
Aytu Bioscience (AYTU) United States $0.017B 0.00
Advaxis (ADXS) United States $0.017B 0.00
TOCAGEN INC (TOCA) United States $0.014B 0.00
TrovaGene (TROV) United States $0.014B 0.00
TRACON Pharmaceuticals (TCON) United States $0.014B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
Cesca Therapeutics (THMO) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.012B 0.00
IMMURON (IMRN) Australia $0.012B 0.00
Cleveland BioLabs (CBLI) United States $0.012B 0.00
Prana Biotechnology (ATHE) Australia $0.011B 0.00
IBio (IBIO) United States $0.010B 0.00
BioPharmX (BPMX) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.005B 0.00